Highest-materiality recent filing
IMAC acknowledges default under senior secured notes and transfers 100% of Ignite Proteomics equity and related assets to collateral agent.
IMAC Holdings issues $175K secured demand promissory note at $125K purchase price
Principal amount $175,000; purchased at $125,000, implying a $50,000 OID.
IMAC Holdings issues $210K secured promissory note at $150K purchase price
Note principal $210,000; proceeds $150,000; effective discount $60,000.
IMAC Holdings issues $222,600 secured promissory note at $159,000 purchase price, due Jan 31, 2026
Issued secured promissory note on Jan 29, 2026 for aggregate principal $222,600; purchase price $159,000.
IMAC Holdings issues $292.6K secured promissory note at 71% of face, due Jan 31, 2026
Note principal $292,600; purchased for $209,000 (71.4% of face value).
IMAC Holdings issues $7.53M senior secured notes due Jan 31, 2026
Aggregate principal $7,530,929.74; purchase price ~$6,332,901.16 via cash and debt conversion.
IMAC Holdings issues $260,400 secured promissory note due Jan 31, 2026
Issued $260,400 principal secured note; purchase price $186,000 (31% discount).
IMAC Holdings issues $247,800 secured note at $177,000; matures Feb 13, 2026
Aggregate principal amount of $247,800; net proceeds of $177,000 (original issue discount of $70,800).
IMAC Holdings issues $245K secured promissory note at $175K purchase price
Principal amount $245,000; purchased for $175,000, implying original issue discount.
IMAC Holdings issues $210K secured promissory note for $150K purchase price
Aggregate principal $210,000; purchase price $150,000; $60,000 original issue discount.
IMAC Holdings issues $285,600 promissory note at $204,000 purchase price
Aggregate principal $285,600; purchase price $204,000 (discount).
IMAC Holdings issues $201,600 promissory note at $144,000 purchase price, matures Dec 24, 2025
Note principal $201,600, purchased for $144,000; unsecured and matures December 24, 2025.
IMAC Holdings issues $296,800 promissory note at $212,000 price, matures Dec 24
Issued unsecured promissory note for aggregate principal of $296,800; purchased at $212,000 (approx. 28.6% OID).
IMAC Holdings issues $179K unsecured note at $128K net; director Pruitt resigns
Issued unsecured promissory note for $179,375 principal, net proceeds $128,125, maturing Dec 24, 2025.
Ignite Proteomics (BACK) enters $420K biomarker study with Inova for GI cancers
Subsidiary Ignite Proteomics will analyze up to 600 tumor samples using RPPA technology.
IMAC Holdings issues $296.8K promissory note at ~28% discount, matures Dec 2025
Issued promissory note with aggregate principal amount of $296,800 for purchase price of $212,000.
IMAC Holdings issues $315k in unsecured promissory notes maturing Dec 2025
Issued two promissory notes on Aug 11-12, 2025: Note 1 $229,600 (purchase $164,000) and Note 2 $85,400 (purchase $61,000).
One-year research collaboration with Vanderbilt University Medical Center; VUMC supplies 80 FFPE breast-cancer samples, Ignite performs RPPA analysis.
IMAC Holdings issues $30,800 promissory note at ~71% face value, matures Dec 2025
Principal amount of $30,800 purchased for $22,000 (71% of face value); unsecured.
IMAC Holdings issues $175K promissory note at $125K purchase price, matures Dec 2025
Issued unsecured promissory note for $175,000 principal; received $125,000 cash from lender.
IMAC Holdings issues $350K promissory note at $250K purchase price due Dec 2025
Issued $350K principal promissory note for $250K purchase price to a lender ($100K OID).
IMAC Holdings issues $84K promissory note at $60K purchase price, due Dec 2025
$84,000 principal unsecured note issued for $60,000 proceeds, maturing December 24, 2025.
IMAC Holdings issues $198,800 promissory note at $142,000 net proceeds, matures Dec 2025
Principal amount of $198,800; purchase price of $142,000; unsecured note.
IMAC Holdings issues $128,800 promissory note at $92,000 purchase price, matures Dec 2025
Principal amount $128,800; purchased for $92,000 (implied discount of $36,800).
IMAC Holdings issues $301K promissory note at $215K purchase price, matures Dec 2025
Issued unsecured promissory note for $301,000 principal; received net proceeds of $215,000.
IMAC Holdings appoints Jason Lobel and Saundra Pelletier to Board of Directors
Appointments effective June 2, 2025; both join as independent directors.
IMAC Holdings issues $455K promissory note at $325K; director resigns
Company issued unsecured promissory note for $455,000 principal, purchased at $325,000, maturing Dec 24, 2025.
IMAC Holdings issues $82,600 promissory note, unsecured, Dec 24, 2025 maturity
$82,600 principal note issued for $59,000 purchase price ($23,600 original issue discount).
IMAC Holdings restates FY2024 and two Q 2024 financials over preferred dividend error
Audit Committee on May 16, 2025 determined Q2 and Q3 2024 and FY 2024 financials unreliable due to non-cash preferred dividend accounting error.
IMAC Holdings issues $275,800 promissory note to lenders, net proceeds $197,000
Aggregate principal of $275,800 issued for purchase price of $197,000 (discount).
IMAC Holdings dismisses Marcum, hires CBIZ CPAs as auditor effective May 2, 2025
Marcum dismissed April 30, 2025; CBIZ CPAs engaged May 2, 2025 for fiscal 2025.
IMAC Holdings issues $139k principal promissory notes at ~$99k discount, maturing Dec 2025
Issued unsecured notes with aggregate principal $139,196.40 for $99,426 purchase price (implied discount ~28.6%).
Aggregate principal amount $239,400; purchase price $171,000 (29% discount).
IMAC Holdings issues $37,089 promissory notes, net proceeds $26,492
Aggregate principal of $37,088.88; purchase price of $26,492 from lenders.
IMAC Holdings issues $50,763 in unsecured promissory notes due December 24, 2025
Aggregate principal $50,763.38, purchase price $36,259.56 (original issue discount).
IMAC Holdings issues $36,050 promissory note with $10,300 OID, matures Dec 24, 2025
Principal $36,050; purchase price $25,750, implying ~28.5% original-issue discount.
IMAC Holdings issues $126,000 in promissory notes to lenders for $90,000 cash
Notes have $126,000 aggregate principal; lenders paid $90,000 purchase price (original issue discount).
On March 24, received Nasdaq suspension/delisting notice for March 26; now trading OTC Pink.
Nasdaq denies IMAC Holdings' appeal; stock to be suspended March 26, delisted
Nasdaq Hearings Panel denied IMAC's request to continue listing; trading suspended at open March 26, 2025.
Nasdaq notified IMAC its stock failed to meet $1.00 minimum bid price for 30 consecutive days; compliance period until Sept 9, 2025.
Issued $150,500 principal promissory notes for $107,500; unsecured, mature upon $1M offering or Nov 18, 2025.
IMAC Holdings files supplement to proxy to clarify Series G issuance proposal
Supplement No. 1 clarifies that Proposal 1 covers potential issuance of common stock below floor prices for Series G preferred and warrants.
IMAC Holdings issues $70K note at 40% discount; amends prior notes
Issued $70,000 principal promissory note to Keystone Capital Partners for $50,000 purchase price.
IMAC Holdings issues $110K promissory notes for $100K net proceeds
Aggregate principal amount of $110,000; purchased by lenders for $100,000, implying $10K original issue discount.
IMAC Holdings faces Nasdaq delisting; seeks shareholder approval for large stock issuances
Filed proxy for March 26 special meeting to approve issuing >19.99% of common stock under Series G Preferred and equity financing.
IMAC Holdings receives Nasdaq delisting notice; intends to appeal by Jan 28
On Jan 21, 2025, Nasdaq notified IMAC it fails minimum stockholders' equity requirement ($2.5M) under Listing Rule 5550(b)(1).
IMAC Holdings regains Nasdaq audit committee compliance; still addressing periodic reporting
Appointed Jeffrey Busch to Audit Committee on Dec 11, 2024; Nasdaq confirmed compliance regained Dec 17, 2024.
IMAC Holdings closes $3.74M PIPE, enters $60M equity line, amends preferred stock terms
Raised $3.74M via PIPE of Series G Preferred Stock (convertible at $1.57) and warrants (exercise price $1.44).
IMAC Holdings issues $140K principal notes at $100K purchase price; repaid Nov 14
Issued unsecured promissory notes for aggregate principal of $140,000, purchased at $100,000 (implicit 40% discount).
IMAC Holdings receives Nasdaq deficiency notices for audit committee vacancy and delayed 10-Q filing
Audit Committee Notice on Nov 21, 2024: vacancy from Cary Sucoff's resignation (Sep 9, 2024) violates Nasdaq Listing Rule 5605.
On June 2, 2025, IMAC Holdings, Inc. (the “Company”) appointed Jason Lobel and Saundra Pelletier as a member of the Board of Directors of the Company.
On June 2, 2025, IMAC Holdings, Inc. (the “Company”) appointed Jason Lobel and Saundra Pelletier as a member of the Board of Directors of the Company.
On May 30, 2025, Jeffrey Busch notified the Board of Directors (the “Board”) of IMAC Holdings, Inc. (the “Company”) of his resignation as director, effective on May 31, 2025.
On September 19, 2024, IMAC Holdings, Inc. (the “Company”) appointed Jeffrey Busch as a member of the Board of Directors of the Company.
On September 6, 2024, Cary Sucoff notified the Board of Directors (the “Board”) of IMAC Holdings, Inc. (the “Company”) of his resignation as director, effective on September 9, 2024.
Peter Beitsch, MD, and Matthew Schwartz, MD joined the Board, effective June 26, 2024.
Peter Beitsch, MD, and Matthew Schwartz, MD joined the Board, effective June 26, 2024.
Also on May 23, 2024, Jeffrey S. Ervin notified the Board of his resignation as Chief Executive Officer and director, effective immediately.
On May 23, 2024, the Company appointed Faith Zaslavsky as Chief Executive Officer of the Company, effective immediately.
On May 23, 2024, Matthew C. Wallis, DC, notified the Board of Directors (the “Board”) of IMAC Holdings, Inc. (the “Company”) of his resignation as director, effective immediately.
On November 24, 2023, Matthew C. Wallis, DC notified the Company of his resignation as the Company’s President, effective as of that date.
On February 28, 2023, Dr. Ben Lerner notified the Company of his resignation as the Company’s Chief Operating Officer to pursue other interests, effective as of February 28, 2023.
Max materiality 0.95 · Median 0.50 · Most common event debt